ANG Lifesciences India Limited (BOM:540694)
24.03
-1.12 (-4.45%)
At close: Jan 19, 2026
ANG Lifesciences India Revenue
ANG Lifesciences India had revenue of 260.54M INR in the quarter ending September 30, 2025, a decrease of -20.77%. This brings the company's revenue in the last twelve months to 922.09M, down -14.37% year-over-year. In the fiscal year ending March 31, 2025, ANG Lifesciences India had annual revenue of 928.47M, down -36.45%.
Revenue (ttm)
922.09M
Revenue Growth
-14.37%
P/S Ratio
0.35
Revenue / Employee
2.24M
Employees
412
Market Cap
324.11M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 928.47M | -532.63M | -36.45% |
| Mar 31, 2024 | 1.46B | -737.81M | -33.55% |
| Mar 31, 2023 | 2.20B | -1.34B | -37.94% |
| Mar 31, 2022 | 3.54B | 2.00B | 129.50% |
| Mar 31, 2021 | 1.54B | 275.48M | 21.72% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Murae Organisor | 8.59B |
| Welcure Drugs and Pharmaceuticals | 3.66B |
| Add-Shop E-Retail | 1.46B |
| Deccan Health Care | 847.12M |
| Walpar Nutritions | 757.46M |
| JFL Life Sciences | 744.78M |
| Sandu Pharmaceuticals | 667.62M |
| Gujarat Terce Laboratories | 501.95M |